View of Clinical Application of Chemiluminescence Microparticle Immunoassay (CMIA) to Measure Antibody Responses After 18 Months of Covid-19 Vaccination and Comparison with Enzyme-Linked Immunosorbent Assay (ELISA)

Return to Article Details Clinical Application of Chemiluminescence Microparticle Immunoassay (CMIA) to Measure Antibody Responses After 18 Months of Covid-19 Vaccination and Comparison with Enzyme-Linked Immunosorbent Assay (ELISA) Download Download PDF